Inflammatory bowel diseases

Keyphrases

Publications

2023

Xin Chen, Charles O Elson, David Dunkin
Epicutaneous Immunotherapy with CBir1 Alleviates Intestinal Inflammation. Inflammatory bowel diseases (2023)
Chunxiao Li, Yu Xu, Tengjiao Gao, Shunyao Zhang, Zhe Lin, Shaobo Gu, Yi Fang, Xin Yuan, Siyi Yu, Qi Jiang, Zhongze Lou, Xiuming Zhang, Jie Zhang, Qiaoyan Wu, Mengli Gu, Xiaoyun Ding, Jing Sun, Yi Chen
Ruxolitinib Alleviates Inflammation, Apoptosis, and Intestinal Barrier Leakage in Ulcerative Colitis via STAT3. Inflammatory bowel diseases (2023)
Romain Ferru-Clément, Gabrielle Boucher, Anik Forest, Bertrand Bouchard, Alain Bitton, Sylvie Lesage, Phil Schumm, Mark Lazarev, Steve Brant, Richard H Duerr, Dermot P B McGovern, Mark Silverberg, Judy H Cho, null null, Ashwin Ananthakrishnan, Ramnik J Xavier, John D Rioux, Christine Des Rosiers
Serum Lipidomic Screen Identifies Key Metabolites, Pathways, and Disease Classifiers in Crohn's Disease. Inflammatory bowel diseases (2023)
Mohammed Ghiboub, Rotem Sigall Boneh, Bruno Sovran, Eytan Wine, Antoine Lefèvre, Patrick Emond, Charlotte M Verburgt, Marc A Benninga, Wouter J de Jonge, Johan E Van Limbergen
Sustained Diet-Induced Remission in Pediatric Crohn's Disease Is Associated With Kynurenine and Serotonin Pathways. Inflammatory bowel diseases (2023)
Julian Panes, Edward V Loftus, Peter D R Higgins, James O Lindsay, Wen Zhou, Xuan Yao, Dapo Ilo, Charles Phillips, Jacinda Tran, Yuri Sanchez Gonzalez, Séverine Vermeire
Induction and Maintenance Treatment With Upadacitinib Improves Health-Related Quality of Life in Patients With Moderately to Severely Active Ulcerative Colitis: Phase 3 Study Results. Inflammatory bowel diseases (2023)
Kelly C Cushing, Yanhua Chen, Xiaomeng Du, Vincent Chen, Annapurna Kuppa, Peter Higgins, Elizabeth K Speliotes
Risk Variants in or Near ZBTB40 AND NFATC1 Increase the Risk of Both IBD and Adverse Bone Health Outcomes Highlighting Common Genetic Underpinnings Across Both Diseases. Inflammatory bowel diseases (2023)
Brigida Barberio, David J Gracie, Christopher J Black, Alexander Charles Ford
Impact of Baseline Disease Activity and Trial Duration on Efficacy of Biologics in Active Crohn's Disease: Meta-analysis. Inflammatory bowel diseases (2023)
Tianming Yu, Wenjing Yang, Suxia Yao, Yanbo Yu, Maki Wakamiya, George Golovko, Yingzi Cong
STING Promotes Intestinal IgA Production by Regulating Acetate-producing Bacteria to Maintain Host-microbiota Mutualism. Inflammatory bowel diseases (2023)
Rachel Q Muir, Barbara J Klocke, Melissa S Jennings, Patrick A Molina, Jung-Shan Hsu, Cailin E Kellum, Katie L Alexander, Goo Lee, Jeremy B Foote, Robin G Lorenz, Jennifer S Pollock, Craig L Maynard
Early Life Stress in Mice Leads to Impaired Colonic Corticosterone Production and Prolonged Inflammation Following Induction of Colitis. Inflammatory bowel diseases (2023)
Kelly C Cushing, Yanhua Chen, Xiaomeng Du, Vincent Chen, Annapurna Kuppa, Peter Higgins, Elizabeth K Speliotes
Risk Variants in or Near ZBTB40 AND NFATC1 Increase the Risk of Both IBD and Adverse Bone Health Outcomes Highlighting Common Genetic Underpinnings Across Both Diseases. Inflammatory bowel diseases (2023)
Aya Ikeda, Reiko Kunisaki, Shigeru Aoki, Katsuki Yaguchi, Akira Madarame, Masafumi Nishio, Tsuyoshi Ogashiwa, Yoshinori Nakamori, Hideaki Kimura, Ryoichi Suzuki, Yusuke Saigusa, Shin Maeda
Appropriate Preconception Corticosteroid-Free Remission Period in Pregnant Women With Ulcerative Colitis. Inflammatory bowel diseases (2023)
Furkan U Ertem, Claudia Ramos Rivers, Andrew R Watson, Gong Tang, Marc Schwartz, Elyse Johnston, Arthur Barrie, Janet Harrison, Jeffrey M Dueker, Doug Hartman, David G Binion
Granuloma Presence at Initial Surgery Predicts Need for Repeat Surgery Independent of Rutgeerts Score in Crohn's Disease. Inflammatory bowel diseases (2023)
Catherine Robbe Masselot, Camille Cordier, Benjamin Marsac, Maria Nachury, Renaud Léonard, Boualem Sendid
Fecal Mucin O-Glycans as Novel Biomarkers in Inflammatory Bowel Diseases. Inflammatory bowel diseases (2023)
Shannon Chang, Simon Hong, David Hudesman, Feza Remzi, Katherine Sun, Wenqing Cao, H Tarik Kani, Jordan E Axelrad, Suparna A Sarkar
Histologic Predictors of Clinical Outcomes and Healthcare Utilization in Patients With Ileal Pouch-Anal Anastomosis. Inflammatory bowel diseases (2023)
David K Choi, Nathaniel A Cohen, Tenzin Choden, Russell D Cohen, David T Rubin
Delays in Therapy Associated With Current Prior Authorization Process for the Treatment of Inflammatory Bowel Disease. Inflammatory bowel diseases (2023)
Laura Sempere, Purificación Bernabeu, José Cameo, Ana Gutiérrez, María Gloria García, Mariana Fe García, Mariam Aguas, Olivia Belén, Pedro Zapater, Rodrigo Jover, Carlos van-der Hofstadt, María Teresa Ruiz-Cantero
Gender Biases and Diagnostic Delay in Inflammatory Bowel Disease: Multicenter Observational Study. Inflammatory bowel diseases (2023)
Roberta Loveikyte, Arno R Bourgonje, Johannes J van der Reijden, Marian L C Bulthuis, Lukas J A C Hawinkels, Marijn C Visschedijk, Eleonora A M Festen, Hendrik M van Dullemen, Rinse K Weersma, Harry van Goor, Andrea E van der Meulen-de Jong, Gerard Dijkstra
Hepcidin and Iron Status in Patients With Inflammatory Bowel Disease Undergoing Induction Therapy With Vedolizumab or Infliximab. Inflammatory bowel diseases (2023)
Francisco Javier García-Alonso, Elizabeth Parody-Rúa, María Chaparro
Efficacy, Effectiveness, and Safety of Ustekinumab for the Treatment of Ulcerative Colitis: A Systematic Review. Inflammatory bowel diseases (2023)
Michael Youssef, Kelly Dong, So Jeong Lee, Neeraj Narula
Histological Remission Placebo Rates in Ulcerative Colitis Trials: A Systematic Review and Meta-analysis. Inflammatory bowel diseases (2023)
Catherine Robbe Masselot, Camille Cordier, Benjamin Marsac, Maria Nachury, Renaud Léonard, Boualem Sendid
Fecal Mucin O-Glycans as Novel Biomarkers in Inflammatory Bowel Diseases. Inflammatory bowel diseases (2023)
Bernd Bokemeyer, Sandra Plachta-Danielzik, Romina di Giuseppe, Wolfgang Mohl, Niels Teich, Martin Hoffstadt, Axel Schweitzer, Manfred von der Ohe, Annika Gauss, Raja Atreya, Thomas Krause, Irina Blumenstein, Petra Hartmann, Stefan Schreiber, null null
Real-world Comparative Effectiveness of Ustekinumab vs Anti-TNF in Crohn's Disease With Propensity Score Adjustment: Induction Phase Results From the Prospective, Observational RUN-CD Study. Inflammatory bowel diseases (2023)
Abigail Raffner Basson, Jeffry Katz, Sargun Singh, Fabiano Celio, Fabio Cominelli, Alexander Rodriguez-Palacios
Sweets and Inflammatory Bowel Disease: Patients Favor Artificial Sweeteners and Diet Foods/Drinks Over Table Sugar and Consume Less Fruits/Vegetables. Inflammatory bowel diseases (2023)
Freddy Caldera, Luke Richard, Mazen Almasry, Hiep Phan, Kelly Chun, Francis A Farraye, Mary S Hayney
Persistence of Antibodies Six Months after Three COVID-19 mRNA Vaccine Doses in Patients with Inflammatory Bowel Disease. Inflammatory bowel diseases (2023)
Sem Geertsema, Antonius T Otten, Dianne G Bouwknegt, Marijn C Visschedijk, Arno R Bourgonje
Assessment of Fecal Glycosylated Mucins as Novel Biomarkers in Inflammatory Bowel Diseases. Inflammatory bowel diseases (2023)
Shintaro Akiyama, Nathaniel A Cohen, Maia Kayal, Marla C Dubinsky, Jean Frederic Colombel, David T Rubin
Treatment of Chronic Inflammatory Pouch Conditions With Tofacitinib: A Case Series From 2 Tertiary IBD Centers in the United States. Inflammatory bowel diseases (2023)
Silvia Salvatori, Giovanni Monteleone
Reply: Frail Phenotype in Patients With Inflammatory Bowel Disease. Inflammatory bowel diseases (2023)
Wei-Chen Lin, Wei-Chen Tai, Chung-Hsin Chang, Chia-Hung Tu, I-Che Feng, Ming-Jium Shieh, Chen-Shuan Chung, Hsu-Heng Yen, Jen-Wei Chou, Jau-Min Wong, Yu-Hwa Liu, Tien-Yu Huang, Chiao-Hsiung Chuang, Tzung-Jiun Tsai, Feng-Fan Chiang, Chien-Yu Lu, Wen-Hung Hsu, Fang-Jung Yu, Te-Hsin Chao, Deng-Chyang Wu, Ai-Sheng Ho, Hung-Hsin Lin, Chun-Lung Feng, Keng-Liang Wu, Ming-Wun Wong, Chien-Chih Tung, Chun-Chi Lin, Chia-Chang Chen, Huang-Ming Hu, Lung-Sheng Lu, Huann-Sheng Wang, I-Chen Wu, Hsin-Yu Kuo, Jia-Feng Wu, Hsiang Yao Shih, Yen-Hsuan Ni, Shu-Lun Tang, Peng-Hsu Chen, Shu Chen Wei
Real-World Evidence of Effectiveness and Safety of Vedolizumab for Inflammatory Bowel Disease in Taiwan: A Prospective Nationwide Registry (VIOLET) Study. Inflammatory bowel diseases (2023)
Hsuan-Ju Lai, Ha T Doan, Elliot Y Lin, Yi-Ling Chiu, Yuan-Kai Cheng, Yi-He Lin, Hao-Sen Chiang
Histones of Neutrophil Extracellular Traps Directly Disrupt the Permeability and Integrity of the Intestinal Epithelial Barrier. Inflammatory bowel diseases (2023)
Rasmus Hvidbjerg Gantzel, Jos Dalvad Vesterdal, Anne-Mette Haase, Alice Juhl Petersen, Henning Grønbæk, Michael Lynge Pedersen
The Prevalence of Inflammatory Bowel Disease in Greenland. Inflammatory bowel diseases (2023)
Daniele Corridoni, Theresa T Pizarro
Single-cell Transcriptomics Reveal the Importance of Distinct Epithelial Cell Populations in Ileal-specific, Treatment-naïve, and Treated Crohn's Disease Patients. Inflammatory bowel diseases (2023)

volume 29, number 2, 2023

Terri Shih, Susy Yusung, Rivkah Gonsky, Rhiannon Dutra-Clarke, David Ziring, Shervin Rabizadeh, Subra Kugathasan, Lee A Denson, Dalin Li, Jonathan G Braun
Environmental Interaction of Resolved Human Cytomegalovirus Infection With Crohn's Disease Location. Inflammatory bowel diseases 29 (2) (2023)
Daniele Corridoni, Theresa T Pizarro
Single-cell Transcriptomics Reveal the Importance of Distinct Epithelial Cell Populations in Ileal-specific, Treatment-naïve, and Treated Crohn's Disease Patients. Inflammatory bowel diseases 29 (2) (2023)
Terri Shih, Susy Yusung, Rivkah Gonsky, Rhiannon Dutra-Clarke, David Ziring, Shervin Rabizadeh, Subra Kugathasan, Lee A Denson, Dalin Li, Jonathan G Braun
Environmental Interaction of Resolved Human Cytomegalovirus Infection With Crohn's Disease Location. Inflammatory bowel diseases 29 (2) (2023)
Terri Shih, Susy Yusung, Rivkah Gonsky, Rhiannon Dutra-Clarke, David Ziring, Shervin Rabizadeh, Subra Kugathasan, Lee A Denson, Dalin Li, Jonathan G Braun
Environmental Interaction of Resolved Human Cytomegalovirus Infection With Crohn's Disease Location. Inflammatory bowel diseases 29 (2) (2023)
Daniele Corridoni, Theresa T Pizarro
Single-cell Transcriptomics Reveal the Importance of Distinct Epithelial Cell Populations in Ileal-specific, Treatment-naïve, and Treated Crohn's Disease Patients. Inflammatory bowel diseases 29 (2) (2023)
Terri Shih, Susy Yusung, Rivkah Gonsky, Rhiannon Dutra-Clarke, David Ziring, Shervin Rabizadeh, Subra Kugathasan, Lee A Denson, Dalin Li, Jonathan G Braun
Environmental Interaction of Resolved Human Cytomegalovirus Infection With Crohn's Disease Location. Inflammatory bowel diseases 29 (2) (2023)

volume 29, number 3, 2023

Catherine Robbe Masselot, Camille Cordier, Benjamin Marsac, Maria Nachury, Renaud Léonard, Boualem Sendid
Fecal Mucin O-Glycans as Novel Biomarkers in Inflammatory Bowel Diseases. Inflammatory bowel diseases 29 (3) (2023)
Rujittika PhD Mungmunpuntipantip, Rujittika Mungmunpuntipantip
Patients With Inflammatory Bowel Disease on Anti-TNF Therapy and COVID-19 Vaccination: Correspondence. Inflammatory bowel diseases 29 (3) (2023)
Hiep Phan, Mary S Hayney, Freddy Caldera
Reply to "Patients With Inflammatory Bowel Disease on Anti-TNF Therapy and COVID-19 Vaccination". Inflammatory bowel diseases 29 (3) (2023)
Sem Geertsema, Antonius T Otten, Dianne G Bouwknegt, Marijn C Visschedijk, Arno R Bourgonje
Assessment of Fecal Glycosylated Mucins as Novel Biomarkers in Inflammatory Bowel Diseases. Inflammatory bowel diseases 29 (3) (2023)
Sem Geertsema, Antonius T Otten, Dianne G Bouwknegt, Marijn C Visschedijk, Arno R Bourgonje
Assessment of Fecal Glycosylated Mucins as Novel Biomarkers in Inflammatory Bowel Diseases. Inflammatory bowel diseases 29 (3) (2023)
Hiep Phan, Mary S Hayney, Freddy Caldera
Reply to "Patients With Inflammatory Bowel Disease on Anti-TNF Therapy and COVID-19 Vaccination". Inflammatory bowel diseases 29 (3) (2023)
Catherine Robbe Masselot, Camille Cordier, Benjamin Marsac, Maria Nachury, Renaud Léonard, Boualem Sendid
Fecal Mucin O-Glycans as Novel Biomarkers in Inflammatory Bowel Diseases. Inflammatory bowel diseases 29 (3) (2023)
Juris Pokrotnieks, Stanislav Sitkin
Helicobacter pylori and Inflammatory Bowel Disease: An Unresolved Enigma. Inflammatory bowel diseases 29 (3) (2023)
Rujittika PhD Mungmunpuntipantip, Rujittika Mungmunpuntipantip
Patients With Inflammatory Bowel Disease on Anti-TNF Therapy and COVID-19 Vaccination: Correspondence. Inflammatory bowel diseases 29 (3) (2023)
Juris Pokrotnieks, Stanislav Sitkin
Helicobacter pylori and Inflammatory Bowel Disease: An Unresolved Enigma. Inflammatory bowel diseases 29 (3) (2023)

volume 29, number 7, 2023

Cong Dai, Yu-Hong Huang
Frail Phenotype in Patients With Inflammatory Bowel Disease. Inflammatory bowel diseases 29 (7) (2023)

volume 29, number 8, 2023

Nannan Zhu, Jiejie Zhu, Qiao Mei
Low-density Granulocytes as a Novel Biomarkers of Disease Activity in IBD. Inflammatory bowel diseases 29 (8) (2023)
Kangzhe Xie, Tamara Ortiz Cerda, Angie Schroder, Nicolette Shiung, Bruno Lemos Wimmer, Belal Chami, Paul K Witting
Response to Low-density Granulocytes as Novel Biomarkers of Disease Activity in IBD. Inflammatory bowel diseases 29 (8) (2023)

volume 29, number 9, 2023

Claudia Herrera-deGuise, Encarna Varela, Guillaume Sarrabayrouse, Marta Pozuelo Del Río, Virginia Robles Alonso, Natalia Borruel Sainz, Francesc Casellas, Luis Fernando Mayorga, Chaysavanh Manichanh, Fernando Azpiroz Vidaur, Francisco Guarner
Gut Microbiota Composition in Long-Remission Ulcerative Colitis is Close to a Healthy Gut Microbiota. Inflammatory bowel diseases 29 (9) (2023)